Drug news
FDFA Advisory Committee recommends QUAD (Gilead) for HIV treatment
The FDA Antiviral Drugs Advisory Committee voted 13-1 that Quad (elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate) from Gilead Sciences, is a safe and effective drug for HIV patients who have not received prior treatment for the disease.The FDA is expected to take action on the application for Quad by August 27.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.